ANCA-associated Vasculitis research hub
4 indexed studies · 2 currently recruiting
- recruiting
Avacostar - (PASS)
This study looks at people with a serious condition called ANCA-associated vasculitis (AAV). It compares a new medicine, avacopan, with standard treatments to see how people get on and if there are any specific health events. It's not a trial where you get a new treatment, but observes real-world care.
Germany · United Kingdom - active not recruiting
Subclinical Cytomegalovirus Reactivation in Acute ANCA-associated Vasculitis
This study looks at how a common virus (CMV) affects people with a rare condition called ANCA-associated vasculitis (AAV), especially when they first get sick or have a flare-up. We want to see if CMV reactivation makes the condition worse.
United Kingdom - recruitingNA
Biocollection of Patients With ANCA Associated Vasculitis
This study is collecting samples like blood and urine from people with a rare condition called ANCA-associated vasculitis. Researchers want to understand the disease better, predict future health issues, and find personalised ways to manage it, ultimately improving lives and treatments.
France - active not recruitingPHASE2
ETA and AT1 Antagonism in ANCA-vasculitis (SPARVASC)
This study looks at a new drug, sparsentan, for people with ANCA-associated vasculitis. It aims to see if blocking certain chemicals can help improve blood vessel health, which is important for preventing heart attacks and strokes in these patients.
United Kingdom